Table 5.
Seroprevalence of SARS-CoV-2 by city.
| Cities | Population | Sex | Mean Age, Years (SD) | Comorbid Conditions | SARS-CoV-2 Vaccination | Seroprevalence, % (95% CI) |
||
|---|---|---|---|---|---|---|---|---|
| Male, n (%) |
Yes, n (%) |
No, n (%) |
Yes, n (%) |
No, n (%) |
||||
| Akanda | 75 | 37 (49.3) | 30 (17) | 8 (10.7) | 67 (89.3) | 10 (13.3) | 65 (86.7) | 89.3 (80–95) |
| Akieni | 11 | 7 (63.6) | 34 (17) | 0 (0) | 11 (100) | 1 (9.1) | 10 (90.9) | 100 (68–100) |
| Bitam | 91 | 46 (50.5) | 24 (15) | 1 (1.1) | 90 (98.9) | 4 (4.4) | 87 (95.6) | 92.3 (84–97) |
| Franceville | 220 | 99 (45) | 31 (19) | 12 (5.5) | 208 (94.5) | 20 (9.1) | 200 (90.9) | 94.5 (91–97) |
| Koulamoutou | 59 | 31 (52.5) | 30 (19) | 6 (10.2) | 53 (89.8) | 9 (15.3) | 50 (84.7) | 96.6 (87–99) |
| Lambaréné | 102 | 44 (43.1) | 26 (21) | 10 (9.8) | 92 (90.2) | 10 (9.8) | 92 (90.2) | 67.6 (58–76) |
| Libreville | 1447 | 751 (51.9) | 35 (15) | 124 (8.6) | 1323 (91.4) | 121 (8.4) | 1326 (91.6) | 90 (88–92) |
| Makokou | 118 | 62 (52.5) | 26 (19) | 8 (6.8) | 110 (93.2) | 15 (12.7) | 103 (87.3) | 84.7 (77–91) |
| Moanda | 83 | 31 (37.3) | 23 (15) | 0 (0) | 83 (100) | 1 (1.2) | 82 (98.8) | 85.5 (76–92) |
| Mouila | 105 | 47 (44.8) | 26 (20) | 7 (6.7) | 98 (93.3) | 6 (5.7) | 99 (94.3) | 88.6 (81–94) |
| Ntoum | 161 | 85 (52.8) | 39 (18) | 9 (5.6) | 152 (94.4) | 3 (1.9) | 158 (98.1) | 88.2 (82–93) |
| Okondja | 57 | 35 (61.4) | 35 (14) | 5 (8.8) | 52 (91.2) | 8 (14) | 49 (86) | 86 (74–93) |
| Owendo | 166 | 73 (44) | 39 (15) | 32 (19.3) | 134 (80.7) | 3 (1.8) | 163 (98.2) | 92.8 (87–96) |
| Oyem | 139 | 57 (41) | 27 (18) | 6 (4.3) | 133 (95.7) | 9 (6.5) | 130 (93.5) | 86.3 (79–91) |
| Port-Gentil | 213 | 94 (44.1) | 37 (15) | 10 (4.7) | 203 (95.3) | 18 (8.5) | 195 (91.5) | 86 (81–91) |
| Tchibanga | 31 | 13 (41.9) | 26 (17) | 0 (0) | 31 (100) | 3 (9.7) | 28 (90.3) | 87.1 (69–96) |
CI, confidence interval, SARS-CoV-2, SD, standard deviation; severe acute respiratory syndrome coronavirus 2.